Vallejos V, Martín-Comín J, Mora J, González M T, Rafecas A, Muñoz A, Fernández A, Castell M, Ricard Y, Ramos M
Servicio de Medicina Nuclear, Ciudad Sanitaria y Universitaria de Bellvitge Hospital Príncipes de España, Feixa Llarga s/n. Hospitalet de Llobregat 08907.
Rev Esp Med Nucl. 1998;17(2):94-101.
The aim of the work was to study the diagnostic value of 99mTc-tetrofosmin to localize anomalous parathyroid glands in patients with hyperparathyroidism.
We have studied 33 patients: 12 with primary and 21 with secondary hyperparathyroidism, 9 of them renal graft recipients. Sixteen patients underwent surgery, 12 with primary and 4 with secondary hyperparathyroidism. All patients were injected with 740 MBq of 99mTc-tetrofosmin. Subsequently at 15, 30 and 60 minutes images were acquired for 300 seconds using a pin-hole collimator. A pertechnetate thyroid scintigraphy was obtained in 7 cases (24-48 h later) when the thyroid activity made difficult the identification of parathyroid glands.
In the group of patients with primary hyperparathyroidism, all cases showed a focal uptake in lower right localization. In the secondary hyperparathyroidism group, 12 patients showed diffuse tracer uptake in two or more glands and histology confirmed hyperplasia in four of them. Seven cases showed a greater focal uptake in a gland: two of them were renal graft recipients and three were chronic renal failure cases in haemodyalisis, and two were evaluated postsurgery showing uptake in the remnant parathyroid gland. The two remaining patients had a normal scintigraphy and corresponded to two false negative cases. In conclusion, our results suggest that 99Tc-tetrofosmin may be used as a suitable tracer for preoperative detection and screening of anomalous parathyroid glands.
本研究旨在探讨99mTc-替曲膦对甲状旁腺功能亢进患者异常甲状旁腺的定位诊断价值。
我们研究了33例患者,其中12例为原发性甲状旁腺功能亢进,21例为继发性甲状旁腺功能亢进,9例为肾移植受者。16例患者接受了手术,其中12例为原发性甲状旁腺功能亢进,4例为继发性甲状旁腺功能亢进。所有患者均注射了740MBq的99mTc-替曲膦。随后在15、30和60分钟时,使用针孔准直器采集300秒的图像。7例患者(24 - 48小时后)进行了高锝酸盐甲状腺闪烁显像,因为甲状腺的活性使得甲状旁腺的识别变得困难。
在原发性甲状旁腺功能亢进患者组中,所有病例在右下部位均显示局灶性摄取。在继发性甲状旁腺功能亢进组中,12例患者在两个或更多腺体中显示弥漫性示踪剂摄取,其中4例经组织学证实为增生。7例患者在一个腺体中显示出更大的局灶性摄取:其中2例为肾移植受者,3例为血液透析的慢性肾衰竭患者,2例术后评估显示残余甲状旁腺有摄取。其余2例患者闪烁显像正常且为假阴性病例。总之,我们的结果表明99Tc-替曲膦可作为术前检测和筛查异常甲状旁腺的合适示踪剂。